Table 3 Correlation between the expression level of selected miRNAs and mRNAs with clinicopathological features. Selected miRNAs and mRNAs were analyzed with Spearman’s non-parametric correlation test and the chi-square test for age, sex, WHO grade, calcification, progesterone receptor status, p53 status, and Ki67 index. Significant results are shown here
Molecule Name | Clinicopathological Features | High | Low | Total | p-Value |
|---|---|---|---|---|---|
miR-29c-3p | Ki67 index | ||||
>7 | 12 | 19 | 31 | 0.0471 | |
≤7 | 17 | 10 | 27 | ||
PTX3 | Progesterone Receptor | ||||
Positive | 16 | 25 | 41 | 0.0002 | |
Negative/Focal Positive/Nuclear Positive | 11 | 0 | 11 | ||
RPL22 | Progesterone Receptor | ||||
Positive | 19 | 22 | 41 | 0.0361 | |
Negative/Focal Positive/Nuclear Positive | 9 | 2 | 11 | ||
CABIN1 | Progesterone Receptor | ||||
Positive | 14 | 27 | 41 | 0.0004 | |
Negative/Focal Positive/Nuclear Positive | 10 | 1 | 11 | ||
SPARCL1 | Progesterone Receptor | ||||
Positive | 16 | 25 | 41 | 0.0022 | |
Negative/Focal Positive/Nuclear Positive | 10 | 1 | 11 | ||
RELA | Calcification | ||||
Positive | 17 | 25 | 42 | 0.0447 | |
Negative | 10 | 4 | 14 | ||
TMOD1 | Calcification | ||||
Positive | 17 | 25 | 42 | 0.0447 | |
Negative | 10 | 4 | 14 | ||